SCHEMBL14348151

SCHEMBL14348151

CCNC(=O)[C@H](C(C)C)[C@H](CCC1CCCC1)C(N)=O

nearest known ligand 0.39

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
METAP2 P50579 2/20 0.39
BCHE P06276 1/20 0.36
SIGMAR1 Q99720 2/20 0.34
METAP1 P53582 1/20 0.34
TSHR P16473 1/20 0.34
ABL1 P00519 1/20 0.33
FGFR3 P22607 1/20 0.33
DDR1 Q08345 1/20 0.33
MAPK11 Q15759 1/20 0.33
MAPK14 Q16539 1/20 0.33
DDR2 Q16832 1/20 0.33
MAP3K20 Q9NYL2 1/20 0.33
MAP3K4 Q9Y6R4 1/20 0.33
CPB2 Q96IY4 5/20 0.32
CTSD P07339 2/20 0.32
REN P00797 1/20 0.32
ALDH1A1 P00352 1/20 0.32
MAPK1 P28482 1/20 0.32
EPHX1 P07099 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8424741 1.00 METAP2 (0.39) METAP2BCHESIGMAR1METAP1TSHR
SCHEMBL8427644 0.94 METAP2 (0.33) METAP2RENALDH1A1MAPK1
SCHEMBL14348143 0.94 METAP2 (0.33) METAP2RENALDH1A1MAPK1
SCHEMBL13913751 0.94 METAP2 (0.33) METAP2RENALDH1A1MAPK1
SCHEMBL8426470 0.84 METAP2 (0.37) METAP2BCHESIGMAR1METAP1TSHR
SCHEMBL14347971 0.84 METAP2 (0.37) METAP2BCHESIGMAR1METAP1TSHR
SCHEMBL8244421 0.84 METAP2 (0.39) METAP2BCHESIGMAR1METAP1TSHR
SCHEMBL14117635 0.84 METAP2 (0.39) METAP2BCHESIGMAR1METAP1TSHR
SCHEMBL13359716 0.83 METAP2 (0.38) METAP2BCHESIGMAR1METAP1TSHR
SCHEMBL14348289 0.83 METAP2 (0.38) METAP2BCHESIGMAR1METAP1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7304056-B2 Succinoylamino lactams as inhibitors of Aβ protein production BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) 2007-12-04 US disclosed
US-7304049-B2 Succinoylaminobenzodiazepines as inhibitors of Aβ protein production BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) 2007-12-04 US disclosed